onr:"swepub:oai:prod.swepub.kib.ki.se:238529711"
Search: onr:"swepub:oai:prod.swepub.kib.ki.se:238529711" > Real-World Healthca...
- 1 of 1
- Previous record
- Next record
- To hitlist
Real-World Healthcare Cost Savings and Reduced Relapse Rate with Off-Label Rituximab versus Disease-Modifying Treatments Approved for Relapsing-Remitting Multiple Sclerosis: A Nationwide Cost-Effectiveness Study
- Alping, P (author)
- Neovius, M (author)
- Piehl, F (author)
- show more...
- show less...
- (creator_code:org_t)
- 2024
- 2024
- English.
- In: Annals of neurology. - 1531-8249.
- Journal article (peer-reviewed)
Subject headings
Close
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- Annals of neurology (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Alping, P
- Neovius, M
- Piehl, F
- Frisell, T
- Articles in the publication
- Annals of neurol ...
- By the university
- Karolinska Institutet
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
